在SORBS2中一种新的误解变体是家族性阿尔茨海默病的致病因
Qi Wang1, Shiyuan Wang1, Shuman Cao1
1Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, People's Republic of China.
CNS neuroscience & therapeutics
|February 6, 2025
概括
一种新的SORBS2基因变异 (T189M) 与中国一家的家族性早期阿尔茨海默病 (AD) 有关. 这种基因突变促进神经炎症和神经元损伤,有助于AD的发病.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 具有重要的遗传成分,但大部分遗传性仍然无法解释.
- 识别新的遗传变异对于理解AD病变的产生至关重要.
- 家庭早期阿尔茨海默病 (EOAD) 为遗传研究提供了有价值的模型.
研究的目的:
- 确定导致家族早期阿尔茨海默病 (EOAD) 的致病基因.
- 阐明索尔宾和SH3域含蛋白2 (SORBS2) 基因在AD病变发生过程中的作用.
主要方法:
- 一个EOAD血统的遗传分析.
- 转基因小鼠SORBS2 T189M的表征.
- 使用莫里斯水迷宫 (MWM) 评估认知功能.
- 粉样β (Aβ) 和炎症标志物的量化.
- 评估神经元形态和损失.
主要成果:
- 一个新的SORBS2变种 (c. 566C>T,p. T189M) 在一个中国家族中被发现,该家族患有家族性AD.
- SORBS2 T189M小鼠表现出认知缺陷,皮质Aβ积累增加,Aβ42/Aβ40比率发生变化.
- 神经炎症标志物 (IL-1β,IL-6,TNF-α,Iba1) 和神经元损失在T189M小鼠中升高.
结论:
- SORBS2 T189M变种是中国血统中家族性AD的潜在因果突变.
- 这种变体通过神经炎症和神经元损伤导致AD病原体.
- 这项研究确定了SORBS2突变与阿尔茨海默病之间的第一个联系.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K
Alternative RNA Splicing
21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K


